Charity organisation Sickle Cell Society has described the recommendation as a “major breakthrough” for sickle cell patients.

The nonaddictive painkiller suzetrigine (Journavx) is as effective for acute pain as a common opioid treatment ...

Live Updates Make sure to refresh this page periodically for updates. Nasdaq Winners and Losers 10:49 am The Nasdaq 100 is ...

"FDA approves Vertex’s acute pain treatment Journavx" was originally created and published by Pharmaceutical Technology, a ...

The company has heavily advertised AI features since the latest iPhones were released in September. Revenue rose 10% from a year ago to $9.5 billion. The shift occurs after many brands cut their ...

Britain's National Health Service (NHS) will provide a cutting-edge gene therapy that aims to cure sickle cell disease, the National Institute for Health and Care Excellence (NICE) said on Friday.

The initial concept to focus on pain-signaling proteins came out of research involving people with a rare hereditary ...

Suki experienced remarkable growth, expanding 4x in only 12 months. This next phase is driven by our latest investments and the expanding opportunities within our addressable market, with technology ...

In a report released today, Greg Harrison from Scotiabank maintained a Buy rating on Liquidia Technologies (LQDA – Research Report), with a ...

ServiceNow and Google Cloud announced a major expansion of their partnership to maximize the value of generative AI across ...

(NASDAQ:VERX) (“Vertex” or the “Company”), a global provider of tax technology solutions, today released the findings of their 2024 U.S. state and local End-of-Year Rates and Rules Report. It ...